ArticleBMC gastroenterology2025
The role of peripheral blood cell analysis-derived inflammatory parameters in predicting malignant duodenal stenosis.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe unique location and complex anatomical structure of the duodenum poses challenges for the application of endoscopic biopsy. Differentiating benign and malignant duodenal stenosis remains difficult for clinicians. Therefore, there is an urgent need for a new, reliable, and cost-effective biomarker to differentiate between benign and malignant duodenal stenosis.
methods140 patients diagnosed with duodenal stenosis during endoscopic examinations and subsequently underwent biopsies or surgery for pathological analysis were enrolled in the study. Based on the pathological results, patients were classified into benign duodenal stenosis group and malignant duodenal stenosis group. Clinical data and results of the initial peripheral blood analysis were collected retrospectively and analyzed.
resultsCompared to patients with benign duodenal stenosis, patients with malignant duodenal stenosis exhibited higher neutrophil-to-lymphocyte ratio (NLR, P < 0.001), platelet-to-lymphocyte ratio (PLR, P < 0.001), and lower lymphocyte-to-monocyte ratio (LMR, P < 0.001). Moreover, an increase in age, NLR, and AST were found to be independent risk factors for malignant duodenal stenosis. Besides, NLR > 3.42 was a more dependable predictor of malignant duodenal stenosis, with a sensitivity of 80.3% and a specificity of 91.1%.
conclusionsPeripheral blood cells analysis derived inflammatory biomarkers such as NLR holds significant predictive value for malignant duodenal stenosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.